Centene (NYSE:CNC) Given Neutral Rating at Cantor Fitzgerald

Centene (NYSE:CNC)‘s stock had its “neutral” rating reaffirmed by analysts at Cantor Fitzgerald in a research note issued to investors on Monday,Benzinga reports. They currently have a $41.00 price objective on the stock. Cantor Fitzgerald’s target price suggests a potential upside of 6.60% from the company’s previous close.

CNC has been the subject of several other research reports. UBS Group set a $42.00 target price on Centene and gave the stock a “neutral” rating in a research report on Thursday, October 30th. Robert W. Baird lifted their price objective on shares of Centene from $28.00 to $36.00 and gave the company a “neutral” rating in a research report on Thursday, December 11th. Mizuho set a $47.00 price target on Centene in a research report on Friday, January 9th. Truist Financial increased their price objective on shares of Centene from $45.00 to $47.00 and gave the company a “buy” rating in a report on Monday, January 5th. Finally, Jefferies Financial Group raised their target price on Centene from $25.00 to $32.00 in a research note on Monday, November 3rd. Three investment analysts have rated the stock with a Buy rating, twelve have given a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $40.81.

Centene Price Performance

CNC opened at $38.46 on Monday. Centene has a twelve month low of $25.08 and a twelve month high of $66.03. The company has a current ratio of 1.10, a quick ratio of 1.08 and a debt-to-equity ratio of 0.87. The firm has a market cap of $18.90 billion, a price-to-earnings ratio of -2.82, a PEG ratio of 0.88 and a beta of 0.48. The company has a fifty day simple moving average of $42.03 and a 200 day simple moving average of $35.99.

Centene (NYSE:CNC) last issued its quarterly earnings data on Friday, February 6th. The company reported ($1.19) earnings per share for the quarter, beating analysts’ consensus estimates of ($1.22) by $0.03. Centene had a positive return on equity of 4.25% and a negative net margin of 3.43%.The firm had revenue of $49.73 billion during the quarter, compared to analyst estimates of $48.41 billion. During the same quarter last year, the firm earned $0.80 EPS. Centene’s quarterly revenue was up 21.9% on a year-over-year basis. Centene has set its FY 2026 guidance at 3.000-3.000 EPS. Equities research analysts expect that Centene will post 6.86 EPS for the current fiscal year.

Hedge Funds Weigh In On Centene

A number of hedge funds have recently added to or reduced their stakes in CNC. Addison Advisors LLC boosted its holdings in Centene by 455.6% in the 3rd quarter. Addison Advisors LLC now owns 739 shares of the company’s stock valued at $26,000 after purchasing an additional 606 shares during the period. Mowery & Schoenfeld Wealth Management LLC bought a new stake in shares of Centene in the third quarter valued at about $27,000. SBI Securities Co. Ltd. grew its position in Centene by 118.4% during the fourth quarter. SBI Securities Co. Ltd. now owns 749 shares of the company’s stock worth $31,000 after buying an additional 406 shares in the last quarter. WPG Advisers LLC increased its position in shares of Centene by 44.5% during the third quarter. WPG Advisers LLC now owns 915 shares of the company’s stock valued at $33,000 after purchasing an additional 282 shares during the period. Finally, Bogart Wealth LLC raised its stake in shares of Centene by 11,011.1% in the 3rd quarter. Bogart Wealth LLC now owns 1,000 shares of the company’s stock valued at $36,000 after buying an additional 991 shares in the last quarter. Institutional investors and hedge funds own 93.63% of the company’s stock.

Centene Company Profile

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.